View Clinical Trial (Medical Research Study)
Outcomes Following Image-Guided Therapy for Hepatic Malignancies
| City: |
|
Nashville |
| State: |
|
Tennessee |
| Zip Code: |
|
37064 |
| Conditions: |
|
Liver Cancer - Metastatic Cancer |
| Purpose: |
|
RATIONALE: Gathering information about quality of life over time from patients with liver
cancer treated with image-guided therapy may help the study of cancer in the future.
PURPOSE: This clinical trial is gathering information about quality of life over time from
patients with liver cancer treated with image-guided therapy.
|
| Study Summary: |
|
OBJECTIVES:
- Develop a data repository for clinical and health-related quality of life outcome
measures in patients with hepatic malignancies treated with image-guided therapies.
OUTLINE: This is a pilot, prospective, longitudinal study.
Patients complete a standard questionnaire assessing health-related quality of life at
baseline, during routine follow-up care after image-guided therapy, and then annually
thereafter. Health and disease status and the development of other illnesses are assessed by
medical record review.
PROJECTED ACCRUAL: Not specified
|
| Criteria: |
|
DISEASE CHARACTERISTICS:
- Undergoing concurrent image-guided therapy for hepatic malignancies using any of the
following imaging techniques:
- X-ray
- Ultrasound
- MRI
- CT scan
- Nuclear medicine imaging
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
|
| NCT ID: |
|
NCT00482586 |
| Primary Contact: |
|
Study Chair
Steven G. Meranze, MD
Vanderbilt-Ingram Cancer Center
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Nashville, Tennessee 37064
United States
Steven G Meranze
Phone: 615-322-3906
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 22, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|